Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma
Authors
Keywords
Hepatocellular carcinoma, Immunotherapy, Immunostimulation, Cellular targets, Molecular targets, Virotherapy, Combinational therapy
Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume 437, Issue 1-2, Pages 13-36
Publisher
Springer Nature
Online
2017-06-07
DOI
10.1007/s11010-017-3092-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-1299 suppresses cell proliferation of hepatocellular carcinoma (HCC) by targeting CDK6
- (2016) Huaqiang Zhu et al. BIOMEDICINE & PHARMACOTHERAPY
- Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma
- (2016) Tong Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumors
- (2016) Timothy T. Spear et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- PD-1 Blockade Boosts Radiofrequency Ablation-Elicited Adaptive Immune Responses against Tumor
- (2016) L. Shi et al. CLINICAL CANCER RESEARCH
- Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma patients after curative resection, a systematic review and meta-analysis
- (2016) Haiqing Wang et al. DIGESTIVE AND LIVER DISEASE
- Immunological basis for treatment of graft versus host disease after liver transplant
- (2016) Vikrant Rai et al. Expert Review of Clinical Immunology
- Rationally combining anti-VEGF therapy with checkpoint inhibitors in hepatocellular carcinoma
- (2016) Tai Hato et al. Immunotherapy
- Tumor-associated macrophage or chemokine ligand CCL17 positively regulates the tumorigenesis of hepatocellular carcinoma
- (2016) Fangyu Zhu et al. MEDICAL ONCOLOGY
- Blocking the CCL2–CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model
- (2016) Kun-Yu Teng et al. MOLECULAR CANCER THERAPEUTICS
- Improvement of the cytotoxic T lymphocyte response against hepatocellular carcinoma by transduction of cancer cells with an adeno-associated virus carrying the interferon-γ gene
- (2016) JUN ZHOU et al. Molecular Medicine Reports
- Suicide gene-modified killer cells as an allogeneic alternative to autologous cytokine-induced killer cell immunotherapy of hepatocellular carcinoma
- (2016) TAO WU et al. Molecular Medicine Reports
- Chemokine CCL15 Mediates Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Hepatocellular Carcinoma
- (2016) Yun Gao et al. STEM CELLS
- Perspectives of immunotherapy in hepatocellular carcinoma (HCC)
- (2016) N. Büttner et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- Expanded and Activated Natural Killer Cells for Immunotherapy of Hepatocellular Carcinoma
- (2016) T. Kamiya et al. Cancer Immunology Research
- Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy
- (2015) Cheng Sun et al. ACTA PHARMACOLOGICA SINICA
- Mechanisms regulating cell membrane localization of the chemokine receptor CXCR4 in human hepatocarcinoma cells
- (2015) Edgar B. Cepeda et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Isolation of vaccinia JX594 from pustules following therapy for hepatocellular carcinoma
- (2015) Che-Hsuan Kung et al. BMC CANCER
- STAT3 inhibition reduces toxicity of oncolytic VSV and provides a potentially synergistic combination therapy for hepatocellular carcinoma
- (2015) S Marozin et al. CANCER GENE THERAPY
- Evaluation of antiglypican-3 therapy as a promising target for amelioration of hepatic tissue damage in hepatocellular carcinoma
- (2015) Randa A. Zaghloul et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
- (2015) Joon Hyeok Lee et al. GASTROENTEROLOGY
- Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma
- (2015) Xiaoguang Li et al. GUT
- Matrix metalloproteinase 10 contributes to hepatocarcinogenesis in a novel crosstalk with the stromal derived factor 1/C-X-C chemokine receptor 4 axis
- (2015) Oihane García-Irigoyen et al. HEPATOLOGY
- CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice
- (2015) Yunching Chen et al. HEPATOLOGY
- CCL15 overexpression predicts poor prognosis for hepatocellular carcinoma
- (2015) YueGuo Li et al. Hepatology International
- Oncolytic Newcastle disease virus expressing chimeric antibody enhanced anti-tumor efficacy in orthotopic hepatoma-bearing mice
- (2015) Ding Wei et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Differential Expression of CX3CL1 in Hepatitis B Virus-Replicating Hepatoma Cells Can Affect the Migration Activity of CX3CR1+Immune Cells
- (2015) Yasuteru Kondo et al. JOURNAL OF VIROLOGY
- Circulating MicroRNAs as Biomarkers in Hepatocellular Carcinoma Screening
- (2015) Li Jiang et al. MEDICINE
- Glypican-3 Targeted Human Heavy Chain Antibody as a Drug Carrier for Hepatocellular Carcinoma Therapy
- (2015) Hirofumi Hanaoka et al. MOLECULAR PHARMACEUTICS
- Phase 1 Study of Intratumoral Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus, in Pediatric Cancer Patients
- (2015) Timothy P Cripe et al. MOLECULAR THERAPY
- Combination cancer immunotherapy and new immunomodulatory targets
- (2015) Kathleen M. Mahoney et al. NATURE REVIEWS DRUG DISCOVERY
- Oncolytic gene therapy with recombinant vaccinia strain GLV-2b372 efficiently kills hepatocellular carcinoma
- (2015) Justin W. Ady et al. SURGERY
- CCL15/CCR1 axis is involved in hepatocellular carcinoma cells migration and invasion
- (2015) Yueguo Li et al. TUMOR BIOLOGY
- Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma
- (2015) Longhao Sun et al. TUMOR BIOLOGY
- PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection
- (2015) Bo-Yi Liao et al. TUMOR BIOLOGY
- Liver disease in menopause
- (2015) Carla W Brady WORLD JOURNAL OF GASTROENTEROLOGY
- A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma
- (2015) Fei Hu et al. Drug Design Development and Therapy
- A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma
- (2015) Yigang Wang et al. Oncotarget
- Characterization of Magnetic Viral Complexes for Targeted Delivery in Oncology
- (2015) Isabella Almstätter et al. Theranostics
- Tumor-infiltrating plasmacytoid dendritic cells promote immunosuppression by Tr1 cells in human liver tumors
- (2015) Alexander Pedroza-Gonzalez et al. OncoImmunology
- GITR engagement in combination with CTLA-4 blockade completely abrogates immunosuppression mediated by human liver tumor-derived regulatory T cellsex vivo
- (2015) Alexander Pedroza-Gonzalez et al. OncoImmunology
- Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma
- (2015) Angela D. Pardee et al. Journal for ImmunoTherapy of Cancer
- Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells
- (2015) Wei Gao et al. PLoS One
- Targeted Hsp70 expression combined with CIK-activated immune reconstruction synergistically exerts antitumor efficacy in patient-derived hepatocellular carcinoma xenograft mouse models
- (2015) Huanzhang Hu et al. Oncotarget
- Suppression of Glypican 3 Inhibits Growth of Hepatocellular Carcinoma Cells through Up-Regulation of TGF-β2
- (2015) Chris K. Sun et al. NEOPLASIA
- pH-Sensitive Nanoformulated Triptolide as a Targeted Therapeutic Strategy for Hepatocellular Carcinoma
- (2014) Daishun Ling et al. ACS Nano
- TREM-1, an Inflammatory Modulator, is Expressed in Hepatocellular Carcinoma Cells and Significantly Promotes Tumor Progression
- (2014) Meng Duan et al. ANNALS OF SURGICAL ONCOLOGY
- NK cells in hepatitis B virus infection: a potent target for immunotherapy
- (2014) Ziba Shabani et al. ARCHIVES OF VIROLOGY
- Using multiple cytokines to predict hepatocellular carcinoma recurrence in two patient cohorts
- (2014) Z-Y Chen et al. BRITISH JOURNAL OF CANCER
- Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy
- (2014) Fu-Liang Bai et al. CANCER BIOLOGY & THERAPY
- Targeting Gene-Virus-Mediated Manganese Superoxide Dismutase Effectively Suppresses Tumor Growth in Hepatocellular Carcinoma In Vitro and In Vivo
- (2014) Fang Huang et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Phosphorothioate-modified CpG oligodeoxynucleotide (CpG ODN) induces apoptosis of human hepatocellular carcinoma cells independent of TLR9
- (2014) Yuyi Zhang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma
- (2014) H. Gao et al. CLINICAL CANCER RESEARCH
- Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy
- (2014) Wei Gao et al. HEPATOLOGY
- miRNA in hepatocellular carcinoma
- (2014) Asahiro Morishita et al. HEPATOLOGY RESEARCH
- Can Toll-Like Receptor (TLR) 2 be considered as a new target for immunotherapy against hepatitis B infection?
- (2014) Vahid Bagheri et al. HUMAN IMMUNOLOGY
- hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo
- (2014) Wen Jiang et al. IMMUNOBIOLOGY
- Genetically engineered Newcastle disease virus expressing interleukin 2 is a potential drug candidate for cancer immunotherapy
- (2014) Fuliang Bai et al. IMMUNOLOGY LETTERS
- Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes
- (2014) YU SAWADA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Anti-Tumor Immune Response of Folate-Conjugated Chitosan Nanoparticles Containing the IP-10 Gene in Mice with Hepatocellular Carcinoma
- (2014) Chunhui Lai et al. Journal of Biomedical Nanotechnology
- Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin
- (2014) Buyun Ma et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Human hepatocellular carcinoma-infiltrating CD4+CD69+Foxp3− regulatory T cell suppresses T cell response via membrane-bound TGF-β1
- (2014) Yanmei Han et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Role of estrogen in hepatocellular carcinoma: is inflammation the key?
- (2014) Liang Shi et al. Journal of Translational Medicine
- Summary of bi-shRNAfurin/GM-CSF Augmented Autologous Tumor Cell Immunotherapy (FANG) in Advanced Cancer of the Liver
- (2014) John Nemunaitis et al. ONCOLOGY
- GPC3 expression in mouse ovarian cancer induces GPC3-specific T cell-mediated immune response through M1 macrophages and suppresses tumor growth
- (2014) CHENHONG LUO et al. ONCOLOGY REPORTS
- Serial Low Doses of Sorafenib Enhance Therapeutic Efficacy of Adoptive T Cell Therapy in a Murine Model by Improving Tumor Microenvironment
- (2014) Hui-Yen Chuang et al. PLoS One
- Oncolytic immunotherapy using recombinant vaccinia virus GLV-1h68 kills sorafenib-resistant hepatocellular carcinoma efficiently
- (2014) Justin W. Ady et al. SURGERY
- Human genes involved in hepatitis B virus infection
- (2014) Zheng Zeng WORLD JOURNAL OF GASTROENTEROLOGY
- Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
- (2014) Chun-Jen Liu WORLD JOURNAL OF GASTROENTEROLOGY
- Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma
- (2014) Koichi Shimizu et al. Human Vaccines & Immunotherapeutics
- A 90Y-labelled anti-ROBO1 monoclonal antibody exhibits antitumour activity against hepatocellular carcinoma xenografts during ROBO1-targeted radioimmunotherapy
- (2014) Kentaro Fujiwara et al. EJNMMI Research
- KIR/HLA immunogenetic background influences the evolution of hepatocellular carcinoma
- (2014) Elisabetta Cariani et al. OncoImmunology
- Sorting Out Pandora’s Box: Discerning the Dynamic Roles of Liver Microenvironment in Oncolytic Virus Therapy for Hepatocellular Carcinoma
- (2014) Jennifer Altomonte et al. Frontiers in Oncology
- Anti-tumor Efficacy of a Hepatocellular Carcinoma Vaccine Based on Dendritic Cells Combined with Tumor-derived Autophagosomes in Murine Models
- (2013) Shu Su et al. Asian Pacific Journal of Cancer Prevention
- Dendritic cells transfected with hepatocellular carcinoma (HCC) total RNA induce specific immune responses against HCC in vitro and in vivo
- (2013) B. H. Xie et al. Clinical & Translational Oncology
- Hepatocellular Carcinoma from an Immunologic Perspective
- (2013) T. F. Greten et al. CLINICAL CANCER RESEARCH
- Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma
- (2013) Jorge Filmus et al. FEBS Journal
- Glypican-3 antibodies: A new therapeutic target for liver cancer
- (2013) Mingqian Feng et al. FEBS LETTERS
- An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosis
- (2013) J Lampe et al. GENE THERAPY
- Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice
- (2013) Tobias Pusterla et al. HEPATOLOGY
- Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in mice
- (2013) Neta Barashi et al. HEPATOLOGY
- MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC)
- (2013) Annalisa Petrelli et al. HEPATOLOGY
- Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis
- (2013) Ju Dong Yang et al. HEPATOLOGY
- Role of cytokine levels in assessment of prognosis and post-treatment outcome in hepatocellular carcinoma
- (2013) Moana Gelu-Simeon et al. Hepatology International
- Potential therapeutic value of dendritic cells loaded with NY-ESO-1 protein for the immunotherapy of advanced hepatocellular carcinoma
- (2013) YUQING CHEN et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Genetic Immunotherapy for Hepatocellular Carcinoma by Endothelial Progenitor Cells Armed with Cytosine Deaminase
- (2013) Rong Chen et al. Journal of Biomedical Nanotechnology
- Natural selection of adaptive mutations in non-structural genes increases trans-encapsidation of hepatitis C virus replicons lacking envelope protein genes
- (2013) C. Fournier et al. JOURNAL OF GENERAL VIROLOGY
- A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
- (2013) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- Combination of SLC administration and Tregs depletion is an attractive strategy for targeting hepatocellular carcinoma
- (2013) Long Chen et al. Molecular Cancer
- Targeting Blockage of STAT3 in Hepatocellular Carcinoma Cells Augments NK Cell Functions via Reverse Hepatocellular Carcinoma-Induced Immune Suppression
- (2013) X. Sun et al. MOLECULAR CANCER THERAPEUTICS
- Antifibrotic Properties of Transarterial Oncolytic VSV Therapy for Hepatocellular Carcinoma in Rats With Thioacetamide-Induced Liver Fibrosis
- (2013) Jennifer Altomonte et al. MOLECULAR THERAPY
- In Vivo Proof of Concept of Adoptive Immunotherapy for Hepatocellular Carcinoma Using Allogeneic Suicide Gene-modified Killer Cells
- (2013) Céline Leboeuf et al. MOLECULAR THERAPY
- 2-Aminopurine Enhances the Oncolytic Activity of an E1b-Deleted Adenovirus in Hepatocellular Carcinoma Cells
- (2013) David Sharon et al. PLoS One
- Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus
- (2013) Elisa Callegari et al. PLoS One
- Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma
- (2013) M. Feng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Remarkable tumor lysis in a hepatocellular carcinoma patient immediately following glypican-3-derived peptide vaccination
- (2013) Yu Sawada et al. Human Vaccines & Immunotherapeutics
- MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA
- (2012) Qingbo Lang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3
- (2012) Kuen-Feng Chen et al. BIOCHEMICAL PHARMACOLOGY
- Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma
- (2012) Roniel Cabrera et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Proinflammatory Myeloid Cell Receptor TREM-1 Controls Kupffer Cell Activation and Development of Hepatocellular Carcinoma
- (2012) Juan Wu et al. CANCER RESEARCH
- Sorafenib Prevents Escape from Host Immunity in Liver Cirrhosis Patients with Advanced Hepatocellular Carcinoma
- (2012) Hidenari Nagai et al. Clinical & Developmental Immunology
- MicroRNAs in Liver Disease
- (2012) Xin Wei Wang et al. GASTROENTEROLOGY
- Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model
- (2012) Elisa Callegari et al. HEPATOLOGY
- Enhancement of tumor-associated antigen-specific T cell responses by radiofrequency ablation of hepatocellular carcinoma
- (2012) Eishiro Mizukoshi et al. HEPATOLOGY
- EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib
- (2012) Zakaria Ezzoukhry et al. INTERNATIONAL JOURNAL OF CANCER
- Local delivery of recombinant adenovirus expressing hepatitis B virus X protein and interleukin-12 results in antitumor effects via inhibition of hepatoma cell growth and intervention of tumor microenvironment
- (2012) HONG HE et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Overexpression of tumor suppressor TSLC1 by a survivin-regulated oncolytic adenovirus significantly inhibits hepatocellular carcinoma growth
- (2012) Guoqing He et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Epithelial-mesenchymal transition and the liver: Role in hepatocellular carcinoma and liver fibrosis
- (2012) Tina Maheswaran et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma
- (2012) Florie Borel et al. JOURNAL OF HEPATOLOGY
- An oncolytic adenovirus regulated by a radiation-inducible promoter selectively mediates hSulf-1 gene expression and mutually reinforces antitumor activity of I131 -metuximab in hepatocellular carcinoma
- (2012) Yan Zhang et al. Molecular Oncology
- The microcosmos of cancer
- (2012) Amaia Lujambio et al. NATURE
- MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein
- (2012) Ying Zhu et al. NUCLEIC ACIDS RESEARCH
- Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study
- (2012) Angela M Liu et al. BMJ Open
- Immunotherapeutic Approaches to Hepatocellular Carcinoma Treatment
- (2012) Alexander G. Miamen et al. Liver Cancer
- Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance
- (2011) Jipeng Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Upregulation of B7-H1 expression is associated with macrophage infiltration in hepatocellular carcinomas
- (2011) Jie Chen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
- (2011) S. A. Rosenberg et al. CLINICAL CANCER RESEARCH
- Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma
- (2011) Eishiro Mizukoshi et al. HEPATOLOGY
- Circulating MicroRNAs as Biomarkers for Hepatocellular Carcinoma
- (2011) Kevin Z. Qu et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma
- (2011) Yoshito Tomimaru et al. JOURNAL OF HEPATOLOGY
- Are there opportunities for chemotherapy in the treatment of hepatocellular cancer?
- (2011) Uzma Asghar et al. JOURNAL OF HEPATOLOGY
- Dovitinib Induces Apoptosis and Overcomes Sorafenib Resistance in Hepatocellular Carcinoma through SHP-1-Mediated Inhibition of STAT3
- (2011) W.-T. Tai et al. MOLECULAR CANCER THERAPEUTICS
- Cell transfer immunotherapy for metastatic solid cancer—what clinicians need to know
- (2011) Steven A. Rosenberg Nature Reviews Clinical Oncology
- Upregulation of Circulating PD-L1/PD-1 Is Associated with Poor Post-Cryoablation Prognosis in Patients with HBV-Related Hepatocellular Carcinoma
- (2011) Zhen Zeng et al. PLoS One
- MicroRNA-122 antagonism against hepatitis C virus genotypes 1-6 and reduced efficacy by host RNA insertion or mutations in the HCV 5' UTR
- (2011) Y.-P. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells
- (2010) Y Tomimaru et al. BRITISH JOURNAL OF CANCER
- Serum microRNA Profiles Serve as Novel Biomarkers for HBV Infection and Diagnosis of HBV-Positive Hepatocarcinoma
- (2010) L.-M. Li et al. CANCER RESEARCH
- Radiofrequency Thermal Ablation for Hepatocellular Carcinoma Stimulates Autologous NK-Cell Response
- (2010) Alessandro Zerbini et al. GASTROENTEROLOGY
- Antitumoural immunity by virus-mediated immunogenic apoptosis inhibits metastatic growth of hepatocellular carcinoma
- (2010) B. Boozari et al. GUT
- Angiogenesis: multiple masks in hepatocellular carcinoma and liver regeneration
- (2010) Ji-An Chen et al. Hepatology International
- WSS25 Inhibits Growth of Xenografted Hepatocellular Cancer Cells in Nude Mice by Disrupting Angiogenesis via Blocking Bone Morphogenetic Protein (BMP)/Smad/Id1 Signaling
- (2010) Hong Qiu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis
- (2010) Peng Gao et al. JOURNAL OF HEPATOLOGY
- Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
- (2010) Jian Xu et al. MOLECULAR CARCINOGENESIS
- Mammalian microRNAs predominantly act to decrease target mRNA levels
- (2010) Huili Guo et al. NATURE
- Hepatitis B and C Viruses and Hepatocellular Carcinoma
- (2010) Birke Bartosch Viruses-Basel
- miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma
- (2009) Mayuko Furuta et al. CARCINOGENESIS
- Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma
- (2009) Q. Gao et al. CLINICAL CANCER RESEARCH
- Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor
- (2009) Bastian Hoechst et al. HEPATOLOGY
- The Case of Oncolytic Viruses Versus the Immune System: Waiting on the Judgment of Solomon
- (2009) Robin J. Prestwich et al. HUMAN GENE THERAPY
- MicroRNA-122 Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells and Sensitizes These Cells to Sorafenib
- (2009) Shoumei Bai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Strong CD8+ T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma
- (2009) Kazumasa Hiroishi et al. JOURNAL OF GASTROENTEROLOGY
- Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
- (2009) Chun-Jen Liu et al. JOURNAL OF HEPATOLOGY
- TGFβ-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3
- (2009) B Wang et al. ONCOGENE
- Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection
- (2009) R. E. Lanford et al. SCIENCE
- Anti-Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer
- (2008) T. Ishiguro et al. CANCER RESEARCH
- Viral and Cellular MicroRNAs as Determinants of Viral Pathogenesis and Immunity
- (2008) Eva Gottwein et al. Cell Host & Microbe
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
- (2008) Xi Chen et al. CELL RESEARCH
- Diagnosis and Treatment of Hepatocellular Carcinoma
- (2008) Hashem B. El-Serag et al. GASTROENTEROLOGY
- Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia
- (2008) HEPATOLOGY
- MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma
- (2008) Wei-Chih Tsai et al. HEPATOLOGY
- Synergistic antitumor effects of transarterial viroembolization for multifocal hepatocellular carcinoma in rats
- (2008) Jennifer Altomonte et al. HEPATOLOGY
- Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
- (2008) Mark E. Dudley et al. JOURNAL OF CLINICAL ONCOLOGY
- Liver Regeneration and Tumor Stimulation—A Review of Cytokine and Angiogenic Factors
- (2008) Christopher Christophi et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
- (2008) Martin A Pule et al. NATURE MEDICINE
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Killing of p53-deficient hepatoma cells by parvovirus H-1 and chemotherapeutics requires promyelocytic leukemia protein
- (2008) Maike Sieben et al. WORLD JOURNAL OF GASTROENTEROLOGY
- PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients
- (2007) Guoping Peng et al. MOLECULAR IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now